Cerebras Systems Inc.

The stock is still in a post-IPO uptrend regime, holding above its 200-day average and well above the 50-day average. Even after the recent pullback, it remains far from the 52-week low and below the 52-week high, which keeps the long-term trend constructive but volatile.

Street sentiment is firmly positive, with a Buy consensus and a median target of 300. Recent calls have trended higher rather than softer: UBS lifted its target to 330, Morgan Stanley to 279, and Mizuho to 310, signaling continued confidence despite the sharp share-price swings.

The earnings profile favors upside surprises, with two straight beats and 76.2% and 71.4% EPS surprises. Next-year EPS estimates sit around 0.96 versus negative 2026 expectations, so shareholders should watch whether revenue growth and margin discipline can bridge the path to profitability.

Recent insider activity leans negative, but most of the volume reflects conversions and other non-discretionary events tied to ownership structure. The clearest signal is Chief Operating Officer Dhiraj Mallick’s cluster of open-market sales, while the other filings are largely automatic or administrative in nature.

Growth is strong, with revenue up 94.4% year over year, and gross margin is a solid 40.3%. The balance sheet is well covered by cash, with $1.11 billion in cash and equivalents versus $261.8 million of debt, though operating margin remains negative at -7.78%.

CBRS stands out as a high-growth AI infrastructure name rather than a mature semiconductor peer, which supports a premium multiple. The current target range of 279 to 330 implies the market is still pricing in substantial execution upside versus the broader chip group.